Web Sify
Follow us on
Sify.com » Topics » Clinic
Clinic News

Media Alert: Pivotal Phase III results for afatinib* in lung cancer to be presented at ASCO 2012
Ingelheim, Germany: FOR NON-US MEDIA ONLY Highly anticipated results from LUX-Lung 3, the pivotal Phase III lung cancer trial investigating Boehringer Ingelheim's front running oncology investigational compound, the ErbB Family Blocker afatinib, in patients with EGFR mutations, will be presented at the 48th Annual Meeting of the American Society of Clinical Oncology